Amy Chudgar MD, Presenter: Nothing to Disclose

Elizabeth McDonald MD, PhD, Abstract Co-Author: Nothing to Disclose

Susan Weinstein MD, Abstract Co-Author: Nothing to Disclose

Phillip Andrew Yamartino BS, Abstract Co-Author: Nothing to Disclose

Emily F. Conant MD, Abstract Co-Author: Scientific Advisory Board, Hologic, Inc

The purpose of this exhibit is to review and compare the common clinical indications for breast MRI in two screening populations: one with digital mammography (DM) and the other with digital breast tomosynthesis (DBT). We will compare utilization rates and pictorially present examples of breast MRI used in the following clinical scenarios: high risk screening, breast cancer staging and problem solving prompted from mammographic findings.

1. Discuss the common clinical indications for breast MRI 2. Pictorial review of breast MRI following DBT or DM screening in the following patient categories: a. High risk screening b. Evaluation of abnormal findings c. Extent of disease in newly diagnosed breast cancer 3. Illustrative examples of both concordant and discordant MR and DM or DBT imaging and a comparison of rates of utilization for problem solving and staging MR will be shown from our experience of over 23,000 DBT screening exam as compared to the year prior of DM only screening.

http://abstract.rsna.org/uploads/2014/14012308/14012308_tqz4.pdf

Chudgar, A, McDonald, E, Weinstein, S, Yamartino, P, Conant, E, Pictorial Review of Breast MRI Utilization in Two Screening Populations: Digital Mammography versus Digital Breast Tomosynthesis..  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14012308.html